AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Company Description
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally.
The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services.
It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals.
The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions.
Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
Country | United States |
IPO Date | Dec 17, 1996 |
Industry | Medical - Diagnostics & Research |
Sector | Healthcare |
Employees | 50,000 |
CEO | James E. Davis |
Contact Details
Address: 500 Plaza Drive Secaucus, New Jersey United States | |
Website | https://www.questdiagnostics.com |
Stock Details
Ticker Symbol | DGX |
Exchange | NYSE |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001022079 |
CUSIP Number | 74834L100 |
ISIN Number | US74834L1008 |
Employer ID | 16-1387862 |
SIC Code | 8071 |
Key Executives
Name | Position |
---|---|
James E. Davis | Chairman, Chief Executive Officer & President |
Sam A. Samad | Executive Vice President & Chief Financial Officer |
Catherine T. Doherty | Executive Vice President of Regional Businesses |
Garry Clark | Senior Vice President and Chief Marketing & Communications Officer |
Karthik Kuppusamy Ph.D. | Senior Vice President of Clinical Solutions |
Kristin Lee Wallace Esq. | Senior Vice President & Chief Compliance Officer |
Michael E. Prevoznik J.D. | Senior Vice President & General Counsel |
Michael J. Deppe | Senior Vice President, Corporate Controller & Chief Accounting Officer |
Murali Balakumar | Senior Vice President, Chief Information & Digital Officer |
Shawn C. Bevec | Vice President of Investor Relations |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Dec 02, 2024 | 4 | Filing |
Dec 02, 2024 | 4 | Filing |
Nov 07, 2024 | 4 | Filing |
Oct 30, 2024 | 4 | Filing |
Oct 25, 2024 | 4 | Filing |
Oct 25, 2024 | 4 | Filing |
Oct 25, 2024 | 4 | Filing |
Oct 25, 2024 | 4 | Filing |
Oct 25, 2024 | 4 | Filing |
Oct 23, 2024 | 10-Q | Quarterly Report |